Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide a new option for COVID-19 vaccination. In October 2021, the World Health Organization set a target for ...

What is a viral vector? Viral vector vaccines use a version of a mild virus to safely deliver instructions in the form of genetic code to our body cells. These instructions enable your body to produce ...

Alignment with National Health Security Goals: GeoVax’s focus on U.S.-based vaccine production supports HHS’s priority of reducing dependency on foreign pharmaceutical supply chains, ensuring ...

The proof-of-concept study is one of the first to combine B and T cell analysis and potentially paves the way for tests that ...

adenovirus vector vaccine (Ad26.COV2.S) and the Novavax protein-based vaccine (NVX-CoV2373). The verdict: the J&J vaccine may ...

This suggested that their mRNA vaccine produced greater immunogenicity than a protein-based vaccine. Additionally, Pine and his colleagues examined the protective efficacies of the three vaccines ...

Recent Studies Support Diversified Vaccine Strategies, Aligning with GeoVax's MVA-Based GEO-CM04S1 for Enhanced Protection, ...

Strengthening U.S. Biodefense. ATLANTA, GA - March 3, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a leader in developing vaccines and immunotherapi ...

As the industry moves towards a more integrated and diversified vaccine ecosystem, GeoVax’s MVA-based vaccines should provide a scalable, durable, and globally accessible solution that enhances the ...